Response to letter by proctor

Stroke

Volumn 39, Issue 5, 2008, Pages

  Dawson, Jesse ^a   Quinn, Terence J ^a   Walters, Matthew R ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; URIC ACID; XANTHINE OXIDASE;

ATHEROSCLEROSIS; CARDIOVASCULAR RISK; DRUG EFFECT; ENZYME ACTIVITY; HUMAN; LETTER; OXIDATIVE STRESS; PRIORITY JOURNAL; STROKE; URIC ACID BLOOD LEVEL;

EID: 66149100937     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.108.515635     Document Type: Letter

References (4)

1. Proctor PH. Uric acid: neuroprotective or neurotoxic. Stroke. 2008;39:e88.
2. Chamorro A, Planas AM. Yin and yang of uric acid in patients with stroke. Response. Stroke. 2004;35:e11-e12.
3. George J, Carr E, Davies J, Belch JJ, Struthers A. High-dose allopurinol improves endothelial function by profoundly reducing vascular oxidative stress and not by lowering uric acid. Circulation. 2006;114:2508 -2516.
4. Høiggen A, Alderman M, Kjeldsen SE, Julius S, Devereux RB, De Faire U, et al. The impact of serum uric acid on cardiovascular outcomes in the LIFE study. Kidney International. 2004;65:1041-1049.